Pioneering psychiatrist Dr. Euripedes C. Miguel reshapes mental health research and treatment in Brazil
University of São Paulo leader in OCD research and developmental psychiatry shares insights on risk factors, innovative treatments, and public policy in "Innovators & Ideas" feature
Genomic Press
image: Euripedes C. Miguel, MD, PhD, Faculdade de Medicina, Universidade de São Paulo, Brazil.
Credit: Brain Medicine, Genomic Press
Euripedes C. Miguel, MD, PhD, a world-leading expert in obsessive-compulsive disorder (OCD) and developmental psychiatry, reflects on his groundbreaking research career and shares his vision for transforming mental healthcare in Brazil and beyond in a candid "Genomic Press Interview." The in-depth profile, featured in the "Innovators & Ideas: Research Leader" section of the journal Brain Medicine (ISSN: 2997-2639, Genomic Press), New York, explores Miguel's professional achievements, research breakthroughs, and personal journey.
As Head of Psychiatry at the University of São Paulo and Director of Brazil's National Institute for Developmental Psychiatry, Miguel has pioneered research on the risk factors, neurobiological underpinnings, and innovative treatments for OCD and other mental health disorders. His work focuses on early identification and intervention strategies to mitigate or prevent psychiatric symptoms, with the aim of translating findings into improved care delivery and public policies.
Through his leadership of the National Center for Science and Innovation in Mental Health (CISM), Miguel spearheads projects to identify modifiable risk and protective factors, develop scalable digital mental health solutions, and implement evidence-based interventions to expand access to treatment. His research combines clinical insights, cutting-edge neuroscience, and a public health perspective to drive real-world impact.
In the wide-ranging "Genomic Press Interview," Miguel opens up about the formative experiences and values that shaped his path as a physician-scientist, his passion for teaching and mentorship, and his relentless pursuit of knowledge to help patients and families affected by mental illness. He shares defining moments in his career, research priorities, and his vision for a future where novel therapies and systemic changes can transform the landscape of mental healthcare.
With a prolific track record of scientific publications, international collaborations, and leadership roles, Miguel's "Innovators & Ideas" feature showcases his tireless commitment to advancing psychiatric research and practice to improve the lives of those facing mental health challenges in Brazil and worldwide. The revealing interview offers an inspiring look at a trailblazing physician-scientist on a lifelong mission to unlock the mysteries of the brain and bring hope through innovation.
For those interested in the intersection of psychiatry, public health, and digital innovation, Dr. Miguel's ongoing research provides a fascinating glimpse into the potential future of mental health care delivery and policy-making in Brazil and globally.
The Genomic Press Interview “Euripedes C. Miguel: Risk factors for obsessive-compulsive and other mental health disorders and their treatment and public policy implications” was published on 05 August 2024 and is freely available online at the website of Brain Medicine (Genomic Press, New York): https://bm.genomicpress.com/aop/.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.